Hackernews posts about Pharma CIO
- FDA makes Lipfendra poster child of CNPV program for first PCSK9 pill (www.fiercepharma.com)
- The Race to Come Up with the Next Big Sleep Drug (www.wsj.com)
- Scientist with 1k Patents Fueling a Drug Powerhouse (www.wsj.com)
- ERP and MES Integration for US Pharma Manufacturers (geekyants.com)
- GPU Management: Why Idle GPUs Are the New Grounded Aircraft (huggingface.co)
- Mohabi: Disaggregating and Sandboxing the Firefox JavaScript Engine (www.usenix.org)
- Where Does Computation End? (sslog.dpdns.org)
- Where Does Computation End? (sslog.dpdns.org)
- India's Battle for Free Internet (web.archive.org)
- A Big Pharma Company Stalled a Potentially Lifesaving Vaccine (www.propublica.org)
- Econ 101 Is Underrated: Pharma Price Controls (marginalrevolution.com)
- Russia is getting Nvidia AI chips from an Indian pharma company (timesofindia.indiatimes.com)
- Genetic Engineering of Plants Can Solve Pharma's Cost Crisis (www.greyb.com)
- Show HN: An open-source implementation of AlphaFold3 (github.com)
- Show HN: We Identified a Counterfeit Pharmaceutical Product in Uzbekistan (yashsm01-glwdj.wordpress.com)
- Show HN: Fauxcquired Podcast about Eli Lilly (open.spotify.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Bayer scores landmark victory as Supreme Court overturns Roundup verdict (www.fiercepharma.com)
- Merck's Lipfendra becomes first oral PCSK9 treatment (www.fiercepharma.com)
- Amid restructuring, Novo Nordisk directs employees to return to office (www.fiercepharma.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- Nature retracts provocative PD-1 study tying lung cancer survival to tx timing (www.fiercepharma.com)
- Takeda, slimming down for 'new era,' plots 4,500 restructuring layoffs (www.fiercepharma.com)
- Pfizer scores FDA nod for hemophilia B gene therapy, will charge $3.5M per dose (www.fiercepharma.com)
- Pharma Giants, Crypto Profits: How Ozempic Could Redefine Corporate Investment (ion-oaie.medium.com)
- How a Mumbai Drugmaker Is Helping Putin Get Nvidia AI Chips (www.bloomberg.com)
- FDA turns up heat on Amgen, proposing to rescind approval of Tavneos (www.fiercepharma.com)
- Stealth scores FDA approval for first Barth syndrome treatment (www.fiercepharma.com)
- Pharma-Marketing.com: The New Pharma Marketing Magazine (www.pharma-marketing.com)